Eculizumab for the Treatment of Severe Antibody-Mediated Rejection: A Case Report and Review of the Literature
In renal transplantation, treatment options for antibody-mediated rejection are limited. Here, we report a case of severe AMR treated with eculizumab. A 50-year-old woman known for end stage kidney disease secondary to IgA nephropathy received a kidney transplant from a 50-year-old deceased donor. A...
Saved in:
| Main Authors: | Duy Tran, Anne Boucher, Suzon Collette, Alexis Payette, Virginie Royal, Lynne Senécal |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Case Reports in Transplantation |
| Online Access: | http://dx.doi.org/10.1155/2016/9874261 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antibody-mediated rejection in heart transplantation
by: V. S. Kvan, et al.
Published: (2022-01-01) -
Targeting CD38 in Antibody-Mediated Rejection
by: Katharina A. Mayer, et al.
Published: (2025-05-01) -
Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection
by: Carrie L. Butler, et al.
Published: (2017-01-01) -
Antibody-Mediated Rejection: An Evolving Entity in Heart Transplantation
by: Sharon Chih, et al.
Published: (2012-01-01) -
Meningococcemia in a vaccinated child receiving eculizumab and review of the literature
by: Diana Üçkardeş, et al.
Published: (2023-02-01)